DATATRAK International, Inc.
$0.30$0.00 (0.0%)
DATATRAK International, Inc.’s quoted price sits in the lower half of its reported 52-week range, 70.3% below the high.
OTC · MAHN · USD
Stock price, dividends
Quote as of Oct 29, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Mid-Atlantic Home Health Network, Inc.’s quoted price sits in the lower half of its reported 52-week range, 92.13% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
THE COMPANY BEHIND THE TICKER
Mid-Atlantic Home Health Network, Inc. provides a comprehensive range of home healthcare solutions and products throughout Virginia, Maryland, and the District of Columbia. Beyond its core offerings, the company also supplies healthcare personnel and specialized private duty nursing services to various institutions, such as hospitals, nursing homes, clinics, correctional facilities, and educational establishments. The firm was initially established as U-Can Resources, Inc. in 1979, later changing its name to Petro-Sers Corporation in 1993, before finally becoming Mid-Atlantic Home Health Network, Inc. in 1994. Its operational base is located in Manassas, Virginia, and it is 80% owned by Oak Springs NursingHome Limited Liability Company.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 01:59 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
KEEP COMPARING
$0.30$0.00 (0.0%)
DATATRAK International, Inc.’s quoted price sits in the lower half of its reported 52-week range, 70.3% below the high.
$0.50$0.00 (0.0%)
CYduct Diagnostics, Inc.’s quoted price sits in the lower half of its reported 52-week range, 82.76% below the high.
$0.03-$0.00 (0.0%)
Bionoid Pharma, Inc.’s quoted price sits in the lower half of its reported 52-week range, 93.3% below the high.
$0.18$0.00 (0.0%)
Escalon Medical Corp.’s quoted price sits in the lower half of its reported 52-week range, 37.93% below the high.
$0.00$0.00 (0.0%)
PharmaCom BioVet, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.01-$0.00 (-7.69%)
Evofem Biosciences, Inc.’s quoted price sits in the lower half of its reported 52-week range, 57.14% below the high.
$0.01$0.00 (0.0%)
NovelStem International Corp.’s quoted price sits in the lower half of its reported 52-week range, 75.0% below the high.
$0.00$0.00 (0.0%)
Arem Pacific Corporation’s quoted price sits in the lower half of its reported 52-week range, 70.0% below the high.